Improving CAR-T cell therapy for solid tumors using targeted radiation treatment
Enhancing CAR-T cell therapy through theranostic targeted radionuclide therapy
This study is exploring a new way to make CAR-T cell therapy even better for treating solid tumors by combining it with a special type of radiation, hoping to help patients fight their cancer more effectively.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10946201 on NIH RePORTER |
What this research studies
This research focuses on enhancing CAR-T cell therapy, a promising cancer treatment, by integrating it with targeted radionuclide therapy. The approach aims to improve the effectiveness of CAR-T cells in treating solid tumors, which have been challenging to target with current therapies. By using a specific type of radiation therapy delivered through CAR-T cells, the study seeks to boost the immune response against tumors and improve patient outcomes. Patients may benefit from this innovative combination therapy that aims to overcome existing limitations in cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who have not responded to conventional therapies or have refractory cancer.
Not a fit: Patients with blood cancers or those who are not eligible for CAR-T cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment options for patients with solid tumors, potentially leading to better outcomes and increased survival rates.
How similar studies have performed: Previous studies have shown promise in combining CAR-T cell therapy with other treatment modalities, suggesting potential for success with this novel approach.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Yang, Yanping — Methodist Hospital Research Institute
- Study coordinator: Yang, Yanping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.